21 – 30 of 76
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial.
(
- Contribution to journal › Article
-
Mark
No evidence for shedding of circulating tumor cells to the peripheral venous blood as a result of mammographic breast compression.
(
- Contribution to journal › Article
- 2012
-
Mark
Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial
(
- Contribution to journal › Article
-
Mark
Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer
(
- Contribution to journal › Article
-
Mark
Breast cancer and spider telangiectasias at diagnosis and its relation to histopathology and prognosis: a population-based study.
(
- Contribution to journal › Article
-
Mark
Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival
(
- Contribution to journal › Article
-
Mark
Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer.
(
- Contribution to journal › Article
-
Mark
Cancer predisposing BARD1 mutations in breast-ovarian cancer families
(
- Contribution to journal › Article
-
Mark
Risk of breast cancer in families of multiple affected women and men
(
- Contribution to journal › Article
-
Mark
Molecular insights on basal-like breast cancer.
(
- Contribution to journal › Article